“myozyme” Archives

Entry Author Date Location
Near-Term FDA Nod Unlikely For Duchenne Drug After Negative Vote 04/25/16 Boston
Standing on a Ledge Once Again, Amicus Holds Breath for Latest Study 08/11/14 New York
Audentes, Loaded With $30M, Pursues Gene Therapy for Rare Diseases 07/26/13 San Francisco
Henri Termeer on Startups, Drug Prices, Getting Older (Part 2) 05/14/13 National
Sarepta’s Muscular Dystrophy Drug Improves With Time; Stock Booms 07/24/12 Seattle
FDA Takes Enforcement Action on Genzyme’s Manufacturing 03/24/10 Boston
FDA to Rule on Genzyme Drug in Six Months 01/21/10 Boston
A Week of Woe for Genzyme, A CPR App for Your iPhone, A Better Treatment for Opioid Dependence, and More Boston-Area Life Sciences News 11/19/09 Boston
FDA Shoots Down Genzyme’s Latest Bid for Pompe Drug Approval 11/16/09 Boston
Genzyme Shares Tank After FDA Discovers Bits of Steel, Rubber in Five Different Drugs 11/13/09 Boston
Genzyme’s Woes Piling Up as FDA Panel Says Data on Leukemia Drug are Lacking 09/01/09 Boston
Genzyme Halts Production at Allston Drug Plant After Virus Appears 06/16/09 Boston
Genzyme Offers Glimpse at Growth Engine, New Drugs for High Cholesterol, Gaucher’s 05/07/09 Boston
Genzyme Fails to Win FDA Approval for Large-Scale Production of Pompe Drug 03/02/09 Boston
Genzyme Nabs Two Key Regulatory Approvals, Expected to Trigger Revenue Growth 02/26/09 Boston
FDA Plans To Clear Genzyme’s Myozyme Made at Large Scale 11/17/08 Boston
FDA Panel Favors Genzyme’s Myozyme 10/22/08 Boston
Genzyme Expects FDA Review of Myozyme Factory by Thanksgiving Weekend 09/23/08 Boston
Arzeda, a University of Washington Spinout, Sees Future in Directed Evolution 09/12/08 Seattle
FDA Decision a Blow For Genzyme—and Biogenerics? 04/22/08 Boston
Page 1 of 1